current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: 1pz7_A mol:protein length:204 Agrin, from PDB0516

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200
# Score Template Links and tools%idFirst EKVIIEKAAGDAEAIAFDGRTYMEYHNAVTKSPDALDYPAEPSEKALQSNHFELSIKTEATQGLILWSGKGLERSDYIALAIVDGFVQMMYDLGSKPVVLRSTVPINTNHWTHIKAYRVQREGSLQVGNEAPITGSSPLGATQLDTDGALWLGGMERLSVAHKLPKAYSTGFIGCIRDVIVDRQELHLVEDALNNPTILHCSAKLast
1 -93.4001pz7_A mol:protein length:204 Agrin  ali model  100  1EKVIIEKAAGDAEAIAFDGRTYMEYHNAVTKSPDALDYPAEPSEKALQSNHFELSIKTEATQGLILWSGKGLERSDYIALAIVDGFVQMMYDLGSKPVVLRSTVPINTNHWTHIKAYRVQREGSLQVGNEAPITGSSPLGATQLDTDGALWLGGMERLSVAHKLPKAYSTGFIGCIRDVIVDRQELHLVEDALNNPTILHCSAK 204
2 -80.8001pz8_A mol:protein length:201 Agrin  ali model follow..  94  1EKVIIEKAAGDAEAIAFDGRTYMEYHNA---VTKSHLSNEIPAEKALQSNHFELSIKTEATQGLILWSGKGLERSDYIALAIVDGFVQMMYDLGSKPVVLRSTVPINTNHWTHIKAYRVQREGSLQVGNEAPITGSSPLGATQLDTDGALWLGGMERLSVAHKLPKAYSTGFIGCIRDVIVDRQELHLVEDALNNPTILHCSAK 201
3 -79.5001q56_A mol:protein length:195 Agrin  ali model follow..  89  1..................GSEKVIIEKAAAIAFDGRTYMEYHSEKALQSNHFELSIKTEATQGLILWSGKGLERSDYIALAIVDGFVQMMYDLGSKPVVLRSTVPINTNHWTHIKAYRVQREGSLQVGNEAPITGSSPLGATQLDTDGALWLGGMERLSVAHKLPKAYSTGFIGCIRDVIVDRQELHLVEDALNNPTILHCSAK 195
4 -75.7003v64_A mol:protein length:191 Low-density lipoprotein receptor-related prot  ali model follow..  66  21.................................ESELTNEIPAEKALQSNHFELSLRTEATQGLVLWIGKAAERADYMALAIVDGHLQLSYDLGSQPVVLRSTVKVNTNRWLRIRAHREHREGSLQVGNEAPVTGSSPLGATQLDTDGALWLGGLQKLPVGQALPKAYGTGFVGCLRDVVVGHRQLHLLEDAVTKPELRPCPT. 190
5 -70.4003pve_A mol:protein length:189 Agrin, Agrin protein  ali model follow..  25  1.......................SLENAGSADFNGFSYLELKGLHLGEKMALEMVFLARGPSGLLLYNGQKTGKGDFVSLALHNRHLEFRYDLGKGAAIIRSKEPIALGTWVRVFLERNGRKGALQVGDGPRVLGESPVPHTMLNLKEPLYVGGAPDFSKLAR-GAAVASGFDGAIQLVSLRGHQLLTQEHVLRAVDVAPFAG. 189
6 -67.8003sh4_A mol:protein length:195 LG3 peptide  ali model follow..  25  7.............................GAYFHDDGFLAFPGSLPEVPETIELEVRTSTASGLLLWQGVEVGEKDFISLGLQDGHLVFRYQLGSGEARLVSEDPINDGEWHRVTALREGRRGSIQVDGEELVSGRSPGPNVAVNAKGSVYIGGAPDVATLTG--GRFSSGITGCVKNLVLHSARPGAPPRAQAGANTRPCPS. 195
7 -60.5002h0b_A mol:protein length:184 Neurexin-1-alpha  ali model follow..  22  2........................SKEEYIATFKGSEYFCYDNPIQSSSDEITLSFKTLQRNGLMLHTGK---SADYVNLALKNGAVSLVINLGSGAFEALVNGKFNDNAWHDVKVTRNLRQVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLP--GSPVSNNFMGCLKEVVYKNNDVRLELSRLAKQGDPKMKIH 182
8 -58.1002r16_A mol:protein length:182 Neurexin-1-alpha  ali model follow..  18  2........................SREATVLSYDGSMFMKIPVVMHTEAEDVSLRFRSQRAYGILMATTSR-DSADTLRLELDAGRVKLTVNLGKGPETLFAGYNLNDNEWHTVRVVRRGKSLKLTVDDQQAMTGQMAGDHTRLEFHN-IETGIITE----RRYLSSVPSNFIGHLQSLTFNGMAY----DLCKNGDIDYCELN 174
9 -57.2001qu0_A mol:protein length:191 LAMININ ALPHA2 CHAIN  ali model follow..  15  6.........................NAESGTYFDGTGFAKAGGFKVGLDLLVEFEFRTTRPTGVLLGISSQ--KMDGMGIEMIDEKLMFHVDNGAGRFTAIIPGHMCNGQWHKVTAKKIKNRLELVVDGNQVDAQSPNSASTSADTNDPVFVGGFPG--GLNQFGLTTNIRFRGCIRSLKLTKGTGKPLELELRGVQPVSCPTT 191
10 -56.2003b3q_E mol:protein length:197 NRXN1 protein  ali model follow..  14  2.................SAFAADPGHAGTTYIFKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYAGRQLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKLNMAAENDANIAI...... 179
11 -55.8001d2s_A mol:protein length:170 SEX HORMONE-BINDING GLOBULIN  ali model follow..  13  13.................................EPIAVMTFDLTKI-TKTSSSFEVRTWDPEGVIFYGDTNPK-DDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVS----GHPIMRIALGGLLF--PASNLRLPLVPALDGCLRRDSWLDKQAEISASA--PTSLRSC... 170
12 -55.5003mw4_A mol:protein length:178 Neurexin-2-beta  ali model follow..  15  2.........................PGSATYIFGKSGGLILYTWPSTRSDRLAVGFSTTVKDGILVRIDSAPGLGDFLQLHIEQGKIGVVFNIGTVDISIKERTPVNDGKYHVVRFTRNGANATLQVDNWPVNEHYPTGRLTIFNTQAQIAIGGKDK-----------GRLFQGQLSGLYYDGLKLNMAAENNPNIKI...... 171
13 -55.0002r1b_A mol:protein length:220 Neurexin-1-beta  ali model follow..  15  1..................GSSLRGGHAGTTYIFKGGGQITYNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRLAIARQRIPYRLGRVVDEWLLDKGGKEQGQPFQGQLSGLYYNGLKLNMAAENDANIAIVPSS.. 220
14 -54.9003vkf_C mol:protein length:181 Neurexin-1-beta  ali model follow..  12  2.........................SGTTYIFSKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEENAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYAGRQLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKLNMAAENDANIAIVVGEVS 181
15 -54.6003mw3_A mol:protein length:208 Neurexin-2-beta  ali model follow..  12  11.................................KGGALITYTDRPSTRMDRLAVGFSTHQRSAVLVRVDSASGLGDYLQLHIDQGTVGVIFNVGTDDITIDPNAIVSDGKYHVVRFTRSGGNATLQVDSWPVNERYPAERLAIARQRIPYRLGRVVDEWLLDKGGRDQGRPFQGQVSGLYYNGLKLALAAESDPNVRT...... 201
16 -54.6003mw2_A mol:protein length:207 Neurexin-1-alpha  ali model follow..  13  9................................SKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRLAIARQRIPYRLGRVVDQATIIIGGKEQGQPFQGQLSGLYYNGLKLNMAAENDANIAIVGNVR. 205
17 -54.1003bod_A mol:protein length:178 Neurexin-1-alpha  ali model follow..  13  3.........................LGSTYIFSKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEENAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKLNMAAENDANIAI...... 171
18 -53.9003bop_A mol:protein length:175 beta-Neurexin 2D4  ali model follow..  12  1..........................ATTYIFGKGGALITYTDRPSTRMDRLAVGFSTHQRSAVLVRVDSASGLGDYLQLHIDQGTVGVIFNVGTDDITIDENAIVSDGKYHVVRFTRSGGNATLQVDSWPVNERYPARQLTIFNSQAAIKIGGRDQ-----------GRPFQGQVSGLYYNGLKLALAAESDPNVHLRLV... 175
19 -53.5001f5f_A mol:protein length:205 SEX HORMONE-BINDING GLOBULIN  ali model follow..  13  25.................................EPIAVMTFDLTKI-TKTSSSFEVRTWDPEGVIFYGDTN-PKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGTSKRHPIMRIALGGLLF--PASNLRLPLVPALDGCLRRDSWLDKQAEISASAPT--SLRSCDVE 191
20 -53.3003biw_E mol:protein length:243 Neurexin-1-beta  ali model follow..  11  26FHGSSKHHSVPIAIYRSPASLRGGHAGTTYIFSKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEENAIINDGKYHVVRFTRSGGNATLQVDSWPVIERPAGRQLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKVNMAAENDANIAI...... 219
21 -52.9002r1d_A mol:protein length:226 Neurexin-1-beta  ali model follow..  12  7HHIHHFHGSSKHHSVPYRSPASLRGGHAGTIFSKGGGQITYKDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKV.................. 192
22 -50.2003asi_A mol:protein length:410 Neurexin-1-alpha  ali model follow..  12  195NQGVCLQQWDGFSCDCSTSFSGPLCNDPGTIFSKGGGQITYNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKLNMAAENDANIAIVGNVR. 396
23 -48.2002jd4_A mol:protein length:383 LAMININ SUBUNIT ALPHA-1  ali model follow..  19  9...............CAVDTAPGYVAGAHQFGLSQNSHLVLQQSDVRKRLQVQLSIRTFASSGLIYYVAHQ-NQMDYATLQLQEGRLHFMFDLGKGRTKVSHPALLSDGKWHTVKTEYIKRKAFMTVDGQESPSVTVVGKATTLDVERKLYLGGLPS-HYRARNIGTITHSIPACIGEIMVNGQQLDKDR-PLSASAVDRCYV. 195
24 -48.1003r05_A mol:protein length:1254 Neurexin-1-alpha  ali model follow..  10 1036NQGVCLQQWDGFSCDCSTSFSGPLCNDPGTTYIKGGGQITYNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPARQLTIFNSQATIIIGGKEQ-----------GQPFQGQLSGLYYNGLKVENDANIAIVGNVRLVGEV 1242
25 -47.5001dyk_A mol:protein length:394 LAMININ ALPHA 2 CHAIN  ali model follow..  22  23...............CVAESEPALLTGSKQFGLSRNSHIAIADTKVKNRLTIELEVRTEAESGLLFYMARI-NHADFATVQLRNGFPYFSYDLGSGDTSTMIPTKINDGQWHKIKIVRVKQEGILYVDDA-SSQTISPKKADILDVVGILYVGGLPI-NYTTRRIGPVTYSLDGCVRNLHMEQAPVDL-DQPTSSFHVGTCFAN 209
26 -45.9001h30_A mol:protein length:422 GROWTH-ARREST-SPECIFIC PROTEIN  ali model follow..  17  41............................LGRMFSGTPVIRLRKRLQPTRLVAEFDFRTFDPEGILLFAGGH-QDSTWIVLALRAGRLELQLRYNGVGRVTSSGPVINHGMWQTISVEELARNLVIKVNRDAVMKIAVAGDLFQPEYHLNLTVGGIPF--HEKDLVQPINPRLDGCMRSWNWLNGEDTTIQETVKVNTRMQCFSV 217
27 -43.1002wjs_A mol:protein length:608 LAMININ SUBUNIT ALPHA-2  ali model follow..  15  385.........................ENVYTVSFPKPGFVELAAVSIDVGTEINLSFSTRNESGIILLGSG--GGQAYYAIFLNKGRLEVHLSSGTRTVIKPEPNRFHDGREHSVHVERTRGIFTVQIDEDRRHMQNLTEE--QPIEVKKLFVGGAPP--EFQPSPLRNIPAFQGCVWNLVINSIPMDFAQPIFKNADIGRCTYQ 562
28 -18.6001za4_A mol:protein length:251 Thrombospondin 1  ali model follow..  12  65........................................VDAVRTEKGFLLLASLRMKKTRGTLLALERKDHSGQVFSVVSKAGTLDLSLT-GKQHVVSVEEALLATGQWKSITLFVQEDRAQLYIDCEKMENAELDVPIQSVFTRDLASIARL--------AKGGVNDNFQGVLQNVRF------FGTTPEDILRNKGCSSS 221
29 -17.6004c1w_A mol:protein length:188 NEURAMINIDASE  ali model follow..  11  27.........................................DKLKKLENATVHMEFKPDAKAPNLFSVSSATKKDEYFTMAVYNNTATLEGRGSDGKNYNDAPLKVKPGQWNSVTFTVEKGRVRLYVNGVLSRTSLRSGNFKDMPDVTHVQIGA-------TKRANNTVWGSNLQIRNLTVYNRALT................. 180
30 -17.6002v73_A mol:protein length:191 PUTATIVE EXO-ALPHA-SIALIDASE  ali model follow..  10  32.......................................DLEKFSSLEEGTIVTRFNMNDTSQSLIGLSDGNKANNYFSLYVSGGKVGYELRRQEGNNVHHSADVTFNRGINTLALKEKGIGAKIFLNGSLVKTVSDPNIKFLNAINNSGFIGK------TDRANGYNEYLFRGNIDFM-------NIYDKPVSDNYLLRKTGE 189
31 -17.1004qvs_A mol:protein length:227 S-layer domain-containing protein  ali model follow..  16  53.................................GVDDYVALPDGIAGTFYNFTIAFDTIGEQPIFDFFDSGSNNKYMRLTAESDGKIKFAMTQSGGEKTITSGSALTEGVWKHVAVTLSGDTGTLYINGENENNTLSLRPLTFLGETSKGYIGK--SHQTDSSEDPYYNSYLHGMIDDFRIFDRALEIKTLASVATRVN..... 227
32 -15.1004kbb_A mol:protein length:459 Botulinum neurotoxin type B  ali model follow..  33KDNNLIDLSGYGAKVEVYDGVELNDKNQFKLTSSANSKIRVTQNQNFLDFSVSFWIRIPKYKN----IINCMKNNSGWKISIRGNRIIWTLIDINGEYNIREDISEYINRWFFVTITNNLNNAKIYINGK-LESNTDIKDIREVIANGEIIFKL----------DGDIDRTQFIWMKYF-------SIFNTELSQSNIEE.... 235
33 -14.1003pme_A mol:protein length:420 Type C neurotoxin  ali model follow..  11  13KKNALVDTSGYNAEVRLEGDVQVNTIYTNDFKLSSGDKIIVNLNNNYENSSVSFWIKISKDLTNEYTIINSIKQNSGWKLCIRNGNIEWILQDINRDYSESLSHTGYTNKWFFVTITNNIGYMKLYINGE-LKQSERIEDLDEVKLDKTIVFG----------IDENIDENQMLWIRDFNIFSKELSNED.............. 209
34 -13.8003azv_A mol:protein length:443 D/C mosaic neurotoxin  ali model follow..  10  62.........................DDRGKVIVTQNENIVYNAMYESFSISFWIRINKWVSNLPGYTIIDSVKNNSGWSIGIISNFLVFTLKQNENSSYDISKNAAGYNKWFFVTITTNMGNMMIYINGK-LIDTIKVKELTGINFSKTITFQM--NKIPNTGLITSDSDNINMWIRDFYIFAKELDDKD.............. 230
35 -13.5003r4s_A mol:protein length:443 Botulinum neurotoxin type C1  ali model follow..  10  73............................................SMYESFSISFWIRINKWVSPGYTIIDSVKNNSGWSIGIISNFLVFTLKQNEDSSYDISNNAPGYNKWFFVTVTNNMGNMKIYINGK-LIDTIKVKELTGINFSKTITFEI--NKIPDTGLITSDSDNINMWIRDF-------YIFAKELDGKDINI.... 227
36 -13.4003obr_A mol:protein length:434 Botulinum neurotoxin type D  ali model follow..  11  20KKNALVDTSGYNAEVRVGDNVQLNTIYTNDFKLSSGDKIIVNLNNNYENSSVSFWIKISKDLTNEYTIINSIEQNSGWKLCIRNGNIEWILQDVNRDYSESLSHTGYTNKWFFVTITNNIGYMKLYINGE-LKQSQKIEDLDEVKLDKTIVFGI----------DENIDENQMLWIRDF-------NIFSKELSNEDINI.... 219
37 -13.3004isq_A mol:protein length:431 Neurotoxin  ali model follow..  53.........................DDRGKVIVTQNENIVYNAMYESFSISFWIRINKWVSNLPGYTIIDSVKNNSGWSIGIISNFLVFTLKQNENSSYDISKNAAGYNKWFFVTITTNMGNMMIYINGK-LIDTIKVKELTGINFSKTITFQM--NKIPNTGLITSDSDNINMWIRDF-------YIFAKELDDKDINI.... 224
38 -13.1001d0h_A mol:protein length:469 PROTEIN (TETANUS TOXIN HC)  ali model follow..  91..............................................FNNFTVSFWLRVPKVSAISSMKKHSLSIGSGWSVSLKGNNLIWTLKDSAGRDLPDKFNAYLANKWVFITITNDRSSANLYINGV-LMGSAEITGLGAIREDNNITLKL----------DRCNNNNQYVSIDKF-------RIFCKALNPKEIEK.... 247
39 -12.9002vxr_A mol:protein length:482 BOTULINUM NEUROTOXIN TYPE G  ali model follow..  53RGGRLIDSSGYGATMNVGSDVIFN-NGQFKLNNSENSNITAHQSKFFDNFSINFWVRTPKYNN----IISCIKNDSGWKVSIKGNRIIWTLIDVNAEYSIKDNISDYINKWFSITITNDRGNANIYINGS-LKKSEKILNLDRINSSNDIDFKL----------INCTDTTKFVWIKDFNIFGRELNATE.............. 255
40 -12.8001fv2_A mol:protein length:472 TETANUS TOXIN HEAVY CHAIN  ali model follow..  98..............................................FNNFTVSFWLRVPKVSAISSMKKHSLSIGSGWSVSLKGNNLIWTLKDSAGEVLPDKFNAYLANKWVFITITNDLSSANLYINGV-LMGSAEITGLGAIREDNNITLKL----------DRCNNNNQYVSIDKF-------RIFCKALNPKEIEK.... 254
41 -12.5003fuq_A mol:protein length:417 BoNT/F (Neurotoxin type F)  ali model follow..  16ENNKFIDISGYGSNISINGDVYIY-RNQFGIYSSKPSEVNIAQNNDYQNFSISFWVRIPKYFN-YTIIDCIRNNNSGWKISLNYNKIIWTLQDTAGNYTQMISISDYINKWIFVTITNNRGNSRIYINGN-LIDEKSISNLGDIHVSDNILFK-----------IVGCNDTRYVGIRYF-------KVFDTELGKTEIET.... 218
42 -12.3002uur_A mol:protein length:245 COLLAGEN ALPHA-1(IX) CHAIN  ali model follow..  10  86...............................................EEYSFLTTFRSTLKKNWNIWQIQDSSGKEQVGIKINGQTQSVVFSYKGLDAAFSNLSSLFDSQWHKIMIGVERSSATLFVD--NRIESLPIKPRGPIDIDGFAVLG---------KLADNPQVSVPFELQWMLIHCDPLRPRRETCHELPARITPSQ 240
43 -12.2003flp_A mol:protein length:217 SAP-like pentraxin  ali model follow..  13  27..........................................TLPAVRQLTVCQRIKPFHRNTGYIFSCATSNQDNQFITSMSDGTLNLGLQVNASSNKYISPIEIELGQWYHVCHVWSGVDGAVYANGSPCGTMENVGKGHQISAGGTVVIGQEQDK------GFEEQESWSGELSDLQVWDEALT................. 174
44 -11.7002vu9_A mol:protein length:444 BOTULINUM NEUROTOXIN A HEAVY CHAIN  ali model follow..  62.................................SSKIEVILKNAIMYENFSTSFWIRIPKYFN----IINCMENNSGWKVSLNYGEIIWTLQDTQEKYSQMINISDYINRWIFVTITNNRNNSKIYINGR-LIDQKPISNLGNIHASNNIMFKL----------DGCRDTHRYIWIKYFNLFDKELNEKE.............. 224
45 -11.6004jra_A mol:protein length:443 Botulinum neurotoxin type A  ali model follow..  62.................................SSKIEVILKNAIMYENFSTSFWIRIPKYFN----IINCMENNSGWKVSLNYGEIIWTLQDTQEKYSQMINISDYINRWIFVTITNNRNNSKIYINGR-LIDQKPISNLGNIHASNNIMFKL----------DGCRDTHRYIWIKYFNLFDKELNEKE.............. 224
46 -10.9004pbp_A mol:protein length:210 C-reactive protein  ali model follow..  15  18.................................TDNSYVKLYPEKPLSLSAFTLCMRVATELPLILFAYYTPDVDELNVWRERDGRVSLY--IQSSKDAAFFRLPPLSTLQTHLCVAWESATGLTAF-DGRRSLHQVYRKGYSIRSGGTVVLGQDPDS------SFDVDQSFVGEIANLQMWDYVLS................. 171
47 -10.8004b1m_A mol:protein length:185 LEVANASE  ali model follow..  11  34.........................IEGKQGRSDGDSFILSSASGSDFTYESDITIKDGNGRALMFRSDKDAKNGYLANVDAKHDLVKFFKFENGAASVIAEKTPIDVNKKYHLKTEAEGDRFKIYLDDRLV-----------IDAHDSVFSEG--------------QFGLNVWDATAVFQNVTKE................. 174
48 -10.5001gyk_A mol:protein length:204 SERUM AMYLOID P-COMPONENT  ali model follow..  11  15.................................SVTDHVNLITPLEKPLQNFTLCFRAYSDAYSLFSYNTQGRDNELLVYKERVGEYSLYI----GRHKVTSKVIEKFPAPVHICVSWESSSGIAEINGTPLVKKGLRQGYF-VEAQPKIVLGQEQDS------KFDRSQSFVGEIGDLYMWDSVLP................. 165
49 -10.0004bdw_A mol:protein length:85 COAGULATION FACTOR XIIA HEAVY CHAIN  ali model follow..  55HGGRCLEVEGHRLCHCPVGYTGPFCDVDTAA............................................................................................................................................................................. 85
50 -9.7603e05_A mol:protein length:204 Precorrin-6Y C5,15-methyltransferase (Decarbo  ali model follow..  11  35..............................................................................KLRLQDDLVMWDIGAGSASVSIEASNLMPNGRIFALERNPQYNLKKFVARNVTLVEAFAPEGLDDLPDPDRVFIGGSGGMEIIDAVDRRLKSEGVIVLNAVTLDTLTKAVEFLEDHGYMVE..... 163
51 -9.7504azz_A mol:protein length:172 LEVANASE  ali model follow..  12  23.........................IEGKQGRSDGDSFILSSASGSDFTYESDITIKDGNGRALMFRSDKDAKNGYLANVDAKHDLVKFFKFENGAASVIAEKTPIDVNKKYHLKTEAEGDRFKIYLDDRLV-----------IDAHDSVFSEG.................................................. 144
52 -9.7401b09_A mol:protein length:206 PROTEIN (C-REACTIVE PROTEIN)  ali model follow..  13  15.................................SDTSYVSLKAPLTKPLKAFTVCLHSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTV----GGSEILFEVPEVTVAPVHICTSWESASGIVEVDGKPRVRKSLKKGYT-VGAEASIILGQEQDSFGGN----EGSQSLVGDIGNVNMWDFVLS................. 167
53 -9.6903v0a_B mol:protein length:1196 NTNH  ali model follow..  884.................................GSNQSISFSNDFLTNSFSIYFWLRNLGKDTIKSKLIGSKEDNCGWEIYFQDTGLVFNMIDSNGNEKNIYLSDVSNNSWHYITIDRLKEQLLIFIDDN-LVANESIKEILNIYSSNIISLLS---------------ENNPSYIEGLTILNKPTTSQE.............. 1030
54 -9.6004dqa_A mol:protein length:355 uncharacterized protein  ali model follow..  17  200.......................................................................................PKDYLEVAGGQNYRVTKPLLTNRWYHVALTYDQPTGKTGINGEKWAGSDWGIDGFDPNSDMGFYIGRIYGFKWG-------ERPFHGKMSEVRVWSVARTENQLKQNMLGVDPASE. 310
55 -9.2501fax_L mol:protein length:96 FACTOR XA  ali model follow..  14NQGKCKDGLGEYTCTCLEGFEGKNCELFTR.............................................................................................................................................................................. 43
56 -9.1301pfx_L mol:protein length:146 FACTOR IXA  ali model follow..  10  58NGGLCKDDINSYECWCQVGFEGKNCELDAT.............................................................................................................................................................................. 87
57 -9.0601sli_A mol:protein length:679 INTRAMOLECULAR TRANS-SIALIDASE  ali model follow..  15  29.........................................KYVKAMTQGTIILSYKSTSENGILFSVGNSTNQDRHFHIYINSGGIGIELRNTDGVFNYTLDRPAGERVFNTVALDAANKQCRLFANGELLATLDKDAFISDITGVDNVTLGGTKR-------QGKIAYPFGGTIGDIKVYSNALSDEELIQAT......... 191

FFAS is supported by the NIH grant R01-GM087218-01
1 1 9 1 0 8   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A. PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem Sci. 2001 Feb;26(2):85-7.